The effect of tumor response on quality of life (QoL) in patients with KRAS wild-type metastatic colorectal cancer (mCRC): Analysis from the CRYSTAL study. Background: Capecitabine has established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback